Abstract
The human immunodeficiency virus (HIV) epidemic in China has expanded rapidly in recent years, but little is known about the prevalence and features of HIV-associated neurocognitive disorders (HANDs) in this part of the world. We administered a comprehensive Western neuropsychological (NP) test battery to 203 HIV+ and 198 HIV − former plasma donors in the rural area of Anhui province. They found that 26% of the HIV − samples, and 46% of the HIV+ samples, were infected with hepatitis C virus (HCV), which can also have central nervous system (CNS) effects. To classify NP impairment, we developed demographically corrected test norms based upon individuals free of both infections (N=141). Using a global summary score, NP impairment was found in 34.2% of the HIV-monoinfected group and 39.7% of the coinfected group, as compared to 12.7% of the uninfected controls (P <.001). HIV+ participants with acquired immunodeficiency syndrome (AIDS) were more likely to be impaired (43%) than non-AIDS individuals (29%; P <.05). Lastly, when all infection groups were combined, participants with NP impairment reported more cognitive complaints (P <.01) and increased dependence in everyday functioning (P=.01). In sum, NP impairment in this large rural Chinese sample was associated with both HIV and HCV infections, and the impairment’s prevalence, severity, and pattern were similar to those reported by Western studies. Clinical significance of NP impairment in this population is suggested by the participants’ reports of reduced everyday functioning. These findings indicate that HAND is likely to be an important feature of HIV infection in developing countries, underscoring the need for international efforts to develop CNS-relevant treatments.
Similar content being viewed by others
References
Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789–1799.
Atkinson JH, Heaton RK, Patterson TL, Wolfson T, Deutsch R, Brown SJ, Summers J, Sciolla A, Gutierrez R, Ellis RJ, Abramson I, Hesselink JR, McCutchan JA, Grant I (2008). Two-year prospective study of major depressive disorder in HIV-infected men. J Affect Disord 108: 225–234.
Beck AT, Steer RA, Ball R, Ranieri W (1996a). Comparison of Beck Depression Inventories -IA and-II in psychiatric outpatients. J Pers Assess 67: 588–597.
Beck AT, Steer RA, Brown GK (1996b). Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation.
Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, Turner BJ, Eggan F, Beckman R, Vitiello B, Morton SC, Orlando M, Bozzette SA, Ortiz-Barron L, Shapiro M (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry 58: 721–728.
Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK (2004). Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26: 307–319.
Carter SL, Rourke SB, Murji S, Shore D, Rourke BP (2003). Cognitive complaints, depression, medical symptoms, and their association with neuropsychological functioning in HIV infection: a structural equation model analysis. Neuropsychology 17: 410–419.
Chelune G, Heaton R, Lehman R (1986). Neuropsychological and personality correlates of patient’s complaints of disability. In: Advances in clinical neuropsychology. Tarter R, Goldstein G, (eds). New York: Plenum Press, pp 95–126.
Cherner M, Letendre S, Heaton RK, Durelle J, Marquie-Beck J, Gragg B, Grant I (2005). Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology 64: 1343–1347.
Clifford DB, Mitike MT, Mekonnen Y, Zhang J, Zenebe G, Melaku Z, Zewde A, Gessesse N, Wolday D, Messele T, Teshome M, Evans S (2007). Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia. J NeuroVirol 13: 67–72.
Cohen J (2004). HIV/AIDS in China: an unsafe practice turned blood donors into victims. Science 304: 1438–1439.
Cysique LA, Deutsch R, Atkinson JH, Young C, Marcotte TD, Dawson L, Grant I, Heaton RK (2007a). Incident major depression does not affect neuropsychological functioning in HIV-infected men. J Int Neuropsychol Soc 13: 1–11.
Cysique LA, Jin H, Franklin DR, Morgan EE, Shi C, Yu X, Wu Z, Taylor MJ, Marcotte TD, Letendre S, Ake C, Grant I, Heaton RK (2007b). Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study. J Int Neuropsychol Soc 13: 781–790.
Cysique LA, Maruff P, Brew BJ (2006). Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology 66: 1447–1450.
Ellis RJ, Deutsch R, Heaton RK, Marcotte TD, McCutchan JA, Nelson JA, Abramson I, Thal LJ, Atkinson JH, Wallace MR, Grant I (1997). Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol 54: 416–424.
First MB, Spitzer RL, Gibbon M, Williams JB (1996). Structured clinical interview for DSM-IV Axis I disorders. New York: Biometrics Research Department.
Forton DM, Thomas HC, Taylor-Robinson SD (2004). Central nervous system involvement in hepatitis C virus infection. Metab Brain Dis 19: 383–391.
Goggin KJ, Zisook S, Heaton RK, Atkinson HJ, Marshall S, McCuthchan JA, Chandler JL, Grant I (1997). Neuropsychological performance of HIV-1 infected men with major depression. J Int Neuropsychol Soc 3: 457–464.
Heaton R, Grant I, Butters N, White DA, Kirson D, Atkinson HJ, McCuthchan JA, Taylor M, Kelly MD, Ellis RJ, Wolfson T, Velin RA, Marcotte TD, Hesselink JR, Jernigan TL, Chandler J, Wallace M, Abramason I (1995). The HNRC 500-Neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc 1: 231–251.
Heaton R, Marcotte TD, Rivera Mindt M, Sadek J, Moore D, Bentley H, McCutchan AJ, Reicks C, Grant I (2004a). The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10: 317–331.
Heaton R, Miller W, Taylor MJ, Grant I (2004b). Revised comprehensive norms for an expended Halstead Reitan Battery: demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz, FL: Psychological Assessmet Resources.
Heaton RK, Velin RA, McCutchan JA, Gulevich SJ, Atkinson JH, Wallace MR, Godfrey HP, Kirson DA, Grant I (1994). Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med 56: 8–17.
Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, Stefaniak M (2004). Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS 18(Suppl 1): S19-S25.
Kessler RC, Abelson J, Demler O, Escobar JI, Gibbon M, Guyer ME, Howes MJ, Jin R, Vega WA, Walters EE, Wang P, Zaslavsky A, Zheng H (2004). Clinical calibration of DSM-IV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMHCIDI). Int J Methods Psychiatr Res 13: 122–139.
Kessler RC, Ustun TB (2004). The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 13: 93–121.
Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ (2008). Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65: 65–70.
Letendre SL, McCutchan JA, Childers ME, Woods SP, Lazzaretto D, Heaton RK, Grant I, Ellis RJ (2004). Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann Neurol 56: 416–423.
Maj, M., Satz, P., Janssen, R., Zaudig, M., Starace, F., D’Elia, L., Sughondhabirom, B., Mussa, M., Naber, D., Ndetei, D., et al. (1994). WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry 51: 51–61.
Maj M, Janssen R, Starace F, Zaudig M, Satz P, Sughond-habirom B, Luabeya MA, Riedel R, Ndetei D, Calil HM, et al. (1994a). WHO Neuropsychiatric AIDS study, cross-sectional phase I. Study design and psychiatric findings. Arch Gen Psychiatry 51: 39–49.
Maj M, Satz P, Janssen R, Zaudig M, Starace F, D’Elia L, Sughondhabirom B, Mussa M, Naber D, Ndetei D, et al. (1994b). WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findings. Arch Gen Psychiatry 51: 51–61.
Marcotte TD, Lazzaretto D, Scott JC, Roberts E, Woods SP, Letendre S (2006). Visual attention deficits are associated with driving accidents in cognitively-impaired HIV-infected individuals. J Clin Exp Neuropsychol 28: 13–28.
Mayeux R, Stern Y, Tang MX, Todak G, Marder K, Sano M, Richards M, Stein Z, Ehrhardt A, Gorman J (1993). Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology 43: 176–182.
Qian HZ, Vermund SH, Kaslow RA, Coffey CS, Chamot E, Yang Z, Qiao X, Zhang Y, Shi X, Jiang Y, Shao Y, Wang N (2006). Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China. AIDS 20: 1429–1435.
Qian HZ, Yang Z, Shi X, Gao J, Xu C, Wang L, Zhou K, Cui Y, Zheng X, Wu Z, Lu F, Lai S, Vermund SH, Shao Y, Wang N (2005). Hepatitis C virus infection in former commercial plasma/blood donors in rural Shanxi Province, China: the China Integrated Programs for Research on AIDS. J Infect Dis 192: 1694–1700.
Riedel D, Ghate M, Nene M, Paranjape R, Mehendale S, Bollinger R, Sacktor N, McArthur J, Nath A (2006). Screening for human immunodeficiency virus (HIV) dementia in an HIV clade C-infected population in India. J NeuroVirol 12: 34–38.
Robertson KR, Nakasujja N, Wong M, Musisi S, Katabira E, Parsons TD, Ronald A, Sacktor N (2007). Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurol 7(8): 1–7.
Royston P, Altman DG (1994). Regression using fractional polynomials of continuous covariates: parsimonious parametric modeling. J R Stat Soc C Appl Stat 43: 429–467.
Ryan EL, Morgello S, Isaacs K, Naseer M, Gerits P (2004). Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology 62: 957–962.
Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, Musisi S, Ronald A, Katabira E (2006). Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 67: 311–314.
Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E (2005). The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 19: 1367–1374.
StataCorp. (2003). Stata Statistical Software: Release 8.0. College Station, TX: Stata Corporation.
Sevigny JJ, Albert SM, McDermott MP, McArthur JC, Sacktor N, Conant K, Schifitto G, Selnes OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Epstein LG, Marder K (2004). Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology 63: 2084–2090.
Sinha S, Satishchandra P (2003). Nervous system involvement in asymptomatic HIV seropositive individuals: a cognitive and electrophysiological study. Neurol India 51: 466–469.
State Council AIDS working Committee Office, United Nations Theme Group on HIV/AIDS in China (2007). A Joint Assessment of HIV/AIDS Prevention, Treatment, and Care in China December 2007. http://www.und-p.org.cn/downloads/otherlocal/HIV/20080104.pdf
Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P (2007). Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr 45: 174–182.
UNAIDS (2006). 2006 AIDS epidemic update. http://data.unaids.org/pub/EpiReport/2006/05-Asia_2006_E-piUpdate_eng.pdf
White DA, Heaton R, Monsch AU (1995). Neuropsychological studies of asymptomatic human immunodeficiency virus-type 1 infected individuals. J Int Neuropsychol Soc 1: 304–315.
Wong MH, Robertson K, Nakasujja N, Skolasky R, Musisi S, Katabira E, McArthur JC, Ronald A, Sacktor N (2007). Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 68: 350–355.
Woods SP, Rippeth JD, Frol AB, Levy JK, Ryan E, Soukup VM, Hinkin CH, Lazzaretto D, Cherner M, Marcotte TD, Gelman BB, Morgello S, Singer EJ, Grant I, Heaton RK (2004). Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol 26: 759–778.
Yepthomi T, Paul R, Vallabhaneni S, Kumarasamy N, Tate DF, Solomon S, Flanigan T (2006). Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus. J Int Neuropsychol Soc 12: 424–430.
Zhao M, Du J, Lu GH, Wang QY, Xu H, Zhu M, McCoy CB (2006). HIV sexual risk behaviors among injection drug users in Shanghai. Drug Alcohol Depend 82(Suppl 1): S43-S47.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
The San Diego HIV Neurobehavioral Research Center (HNRC) group is affiliated with the University of California, San Diego, the Naval Hospital, San Diego, and the Veterans Affairs San Diego Healthcare System, and includes Director: Igor Grant, MD; Co-Directors: J. Hampton Atkinson, MD, Ronald J. Ellis, MD, PhD, and J. Allen McCutchan, MD; Center Manager: Thomas D. Marcotte, PhD; Naval Hospital San Diego: Braden R. Hale, MD, MPH (P.I.); Neuromedical Component: Ronald J. Ellis, MD, PhD (P.I.), J. Allen McCutchan, MD, Scott Letendre, MD, Edmund Capparelli, PharmD, Rachel Schrier, PhD; Neurobehavioral Component: Robert K. Heaton, PhD (P.I.), Mariana Cherner, PhD, Steven Paul Woods, PsyD; Neuroimaging Component: Terry Jernigan, PhD (P.I.), Christine Fennema-Notestine, PhD, Sarah L., Archibald, MA, John Hesselink, MD, Jacopo Annese, PhD, Michael J. Taylor, PhD, Neurobiology Component: Eliezer Masliah, MD (P.I.), Ian Everall, FRCPsych, FRCPath, PhD, Cristian Achim, MD, PhD.; Neurovirology Component: Douglas Richman, MD, (P.I.), David M. Smith, MD; International Component: J. Allen McCutchan, MD, (P.I.); Developmental Component: Ian Everall, FRCPsych, FRCPath, PhD (P.I.), Stuart Lipton, MD, PhD; Clinical Trials Component: J. Allen McCutchan, MD, J. Hampton Atkinson, MD, Ronald J. Ellis, MD, PhD, Scott Letendre, MD; Participant Accrual and Retention Unit: J. Hampton Atkinson, MD (P.I.), Rodney von Jaeger, M.P.H.; Data Management Unit: Anthony C. Gamst, PhD (P.I.), Clint Cushman, BA, (Data Systems Manager), Daniel R. Masys, MD (Senior Consultant); Statistics Unit: Ian Abramson, PhD (P.I.), Christopher Ake, PhD, Florin Vaida, PhD.
This study was supported by the NIMH grant 5 R01 MH073433-04 (Dr. Heaton, P.I.). The HIV Neurobehavioral Research Center (HNRC) is supported by Center award MH 62512 from NIMH.
Rights and permissions
About this article
Cite this article
Heaton, R.K., Cysique, L.A., Jin, H. et al. Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. Journal of NeuroVirology 14, 536–549 (2008). https://doi.org/10.1080/13550280802378880
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/13550280802378880